HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
XL518
Description
XL518 is an orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity being developed by Exelixis.
No brand information found.
